---
title: "Protalix Biotherap (PLX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PLX.US/norm.md"
symbol: "PLX.US"
name: "Protalix Biotherap"
parent: "https://longbridge.com/en/quote/PLX.US.md"
datetime: "2026-05-21T15:20:14.855Z"
locales:
  - [en](https://longbridge.com/en/quote/PLX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PLX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PLX.US/norm.md)
---

# Protalix Biotherap (PLX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.2200 | -0.0692 | 0.0297 | 0.0020 | -0.0500 |
| ROE | 126.92% | -43.54% | 18.32% | 1.38% | -32.74% |
| Revenue | 33.75M | 9.12M | 17.85M | 15.66M | 10.11M |
| Net income | 18.32M | -5.50M | 2.35M | 164000.00 | -3.62M |
| Operating income | 21.15M | -4.66M | 2.13M | 1.17M | -4.14M |
| Gross margin | 87.77% | -157.71% | 53.37% | 62.51% | 19.11% |
| Net margin | 54.27% | -60.34% | 13.19% | 1.05% | -35.79% |
| Profit quality | 96.01% | -229.46% | -57.10% | -22.40% | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 102.34M | 82.35M | 82.26M | 78.49M | 73.89M |
| Leverage | 1.52 | 1.71 | 1.55 | 1.57 | 1.63 |
| BVPS | 0.8344 | 0.5997 | 0.6585 | 0.6259 | 0.5786 |
| Turnover | 0.8668 | 0.6772 | 0.8599 | 0.7287 | 0.7301 |
| Cash & STI | 51.08M | 30.27M | 29.37M | 33.40M | 34.74M |
| Inv & Rec | 30.47M | 25.73M | 21.25M | 21.13M | 19.51M |
| LT assets | 12.95M | 12.58M | 12.53M | 9.74M | 9.95M |
| Net debt | -42.60M | -21.95M | -21.19M | -28.05M | -29.51M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 22.02M | 2.03M | -3.73M | -5.23M | -5.06M |
| Investing CF | 4.22M | -1.11M | -504000.00 | -438000.00 | -312000.00 |
| Financing CF | 150000.00 | 146000.00 | 0.0000 | 4.10M | 5.08M |
| Free CF | 15.34M | 3.12M | -5.91M | -5.93M | -3.76M |
| OCF coverage | 2894.22% | 503.72% | -749.40% | -1214.15% | -1652.94% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -761000.00 | -403000.00 | -498000.00 | -431000.00 | -306000.00 |